Annual Accounts Receivable
N/A
December 31, 2024
Summary
- XLO annual accounts receivable is not available.
Performance
XLO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
XLO Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
XLO Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
Xilio Therapeutics Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $1.53 M(-67.3%) | - |
Dec 2022 | $4.66 M(+1551.4%) | - |
Dec 2021 | $282.10 K(-86.3%) | - |
Dec 2020 | $2.05 M(+386.3%) | - |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | $422.10 K(+41.6%) | - |
Dec 2018 | $298.00 K(+234.8%) | - |
Dec 2017 | $89.00 K(+41.3%) | - |
Dec 2016 | $63.00 K | - |
FAQ
- What is the all time high annual accounts receivable for Xilio Therapeutics?
What is the all time high annual accounts receivable for Xilio Therapeutics?
Xilio Therapeutics all-time high annual accounts receivable is $4.66 M